The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ilyukhin E.A.

Kurginyan Kh.M.

Authors’ response for comments by Sapelkin S.V. on the article by E.A. Ilyukhin et al. “«Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024;18(2):122-131)

Authors:

Ilyukhin E.A., Kurginyan Kh.M.

More about the authors

Journal: Journal of Venous Disorders. 2025;19(1): 45‑48

DOI: 10.17116/flebo20251901145

Read: 627 times

Buy for 300₽
Contact the author
Table of contents

AUTHORS’ RESPONSE FOR COMMENTS BY SAPELKIN S.V. ON THE ARTICLE BY E.A. ILYUKHIN ET AL. “«IMPACT OF MICRONIZED PURIFIED FLAVONOID FRACTION ON VENOUS SYMPTOMS AFTER ENDOVENOUS LASER ABLATION: A RANDOMIZED CONTROLLED TRIAL DEMO» (PHLEBOLOGY 2024;18(2):122-131)
AUTHORS’ RESPONSE FOR COMMENTS BY SAPELKIN S.V. ON THE ARTICLE BY E.A. ILYUKHIN ET AL. “«IMPACT OF MICRONIZED PURIFIED FLAVONOID FRACTION ON VENOUS SYMPTOMS AFTER ENDOVENOUS LASER ABLATION: A RANDOMIZED CONTROLLED TRIAL DEMO» (PHLEBOLOGY 2024;18(2):122-131)

To cite this article:

Ilyukhin EA, Kurginyan KhM. Authors’ response for comments by Sapelkin S.V. on the article by E.A. Ilyukhin et al. “«Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024;18(2):122-131). Journal of Venous Disorders. 2025;19(1):45‑48. (In Russ.)
https://doi.org/10.17116/flebo20251901145

 
Подписка 2026 Флебология (Journal of Venous Disorders)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Authors’ response for comments by Sapelkin S.V. on the article by E.A. Ilyukhin et al. “«Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024;18(2):122-131).

Authors:

Ilyukhin E.A.

Kurginyan Kh.M.

Received:

24.12.2024

Accepted:

24.01.2025

Close metadata

References:

  1. https://doi.org/10.17116/flebo20251901143  https://doi.org/10.17116/flebo20251901143
  2. Ilyukhin EA, Kurginyan KhM, Kovalenko KE, Norvardyan AM, Abukhamdan AS, Gevorgyan AA, Kartoev IR. Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO. Journal of Venous Disorders. 2024;18(2):122-131. (In Russ.). https://doi.org/10.17116/flebo202418021122
  3. Ilyukhin EA, Abramova SA, Verbitsky NS, Voronin MS, Gerasimova DE, Kamardin FI, Kostromitin NE, Nurtdinov AR, Skorobogatov OA, Stoiko YuM. Multiple-Center Prospective Observational Trial on Assessment of the Compliance of Patients with Chronic Venous Insufficiency to Sulodexide Therapy in Routine Outpatient Practice ALLEGRO. Journal of Venous Disorders. 2020;14(2):74-82. (In Russ.). https://doi.org/10.17116/flebo20201402174
  4. Iliukhin EA. Effectiveness of the Oral Form of Sulodexide in the ALLEGRO Observational Trial. Journal of Venous Disorders. 2020;14(2):113-121. (In Russ.). https://doi.org/10.17116/flebo202014021113
  5. Ilyukhin EA. Oral Form of Sulodexide for Varicose Veins with Chronic Venous Insufficiency: Data of the ALLEGRO Observational Trial. Journal of Venous Disorders. 2020;14(4):304-310. (In Russ.) https://doi.org/10.17116/flebo202014041304
  6. Ilyukhin EA, Pikhanova ZhM. Oral Sulodexide in Patients with Postthrombotic Syndrome and Chronic Venous Insufficiency (C3—C4, Es): a Subanalysis of Data from the Observational Study ALLEGRO. Journal of Venous Disorders. 2021;15(1):24-32. (In Russ.). https://doi.org/10.17116/flebo20211501124
  7. Ilyukhin EA, Kurginyan KhM. Authors’ response to Lobastov K.V. regarding the results of two randomized controlled trials “DEMO” and “GOLIATH” published by Ilyukhin E.A. et al. (Journal of Venous Disorders. 2024;18(2): 122-131, 139-152). Journal of Venous Disorders. 2024;18(4):353-354. (In Russ.) https://doi.org/10.17116/flebo202418041353 
  8. Perrin M, Eklof B, VAN Rij A, Labropoulos N, Vasquez M, Nicolaides A, Blattler W, Bouhassira D, Bouskela E, Carpentier P, Darvall K, DE Maeseneer M, Flour M, Guex JJ, Hamel-Desnos C, Kakkos S, Launois R, Lugli M, Maleti O, Mansilha A, NEGLéN P, Rabe E, Shaydakov E. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol J Int Union Angiol. 2016;35(4):374-398. 
  9. Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Tatarintsev AM, Kirienko AI. Risk factors for venous symptoms in Russian patients with chronic venous disease. Curr Med Res Opin. 2019 Sep;35(9):1583-1587. 1605050. Epub 2019 May 13. PMID: 30958033. https://doi.org/10.1080/03007995.2019.
  10. Kuznetsov MR, Bogachev VYu, Sapelkin SV, Marchenko IP, Neskhodimov LA, Khotinskiy AA. Pleiotropic therapy for the initial stages of chronic venous insufficiency in post-thrombotic disease. Ambulatornaya khirurgiya=Ambulatory Surgery. 2020;(3-4):20-26. (In Russ.). https://doi.org/10.21518/1995-1477-2020-3-4-20-26
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.